跳至主要内容
临床试验/NCT00874887
NCT00874887已完成4 期

A Clinical Study to Evaluate if Benzalkonium Chloride (BAK) in a Quinolone Eyedrop Reduces the Likelihood of Developing Resistant Organisms

Allergan0 个研究点目标入组 66 人开始时间: 2009年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
Allergan
入组人数
66
主要终点
Percentage of Subjects With Strain Resistance of the Conjunctiva as Determined by Minimum Inhibitory Concentration (MIC) at Day 14

研究概览

简要总结

The purpose of this study is to assess if the presence of BAK in a fluoroquinolone in the study eye affects the development of resistant bacteria on the conjunctiva based upon changes in the surface flora over the course of 2 weeks of topical treatment in healthy adult subjects.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Single (Investigator)

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or Female
  • At least 50 years of age
  • In good general health

排除标准

  • Any ocular surgery or use of topical antibiotics or antiseptics in either eye within the last 3 months
  • Use of topical steroids, or non-steroidal anti inflammatory drugs in either eye within 30 days of Baseline (or anticipated during the study)
  • Use of lid scrubs within 7 days of Baseline in either eye (or anticipated use during the study)

研究组 & 干预措施

Vigamox®

Active Comparator

moxifloxacin 0.5% (m mg/mL), boric acid, sodium chloride, and purified water

干预措施: moxifloxacin 0.5% HCI ophthalmic solution (Drug)

Zymar®

Active Comparator

gatifloxacin 0.3% (3 mg/mL), benzalkonium chloride 0.005%, edetate disodium; purified water and sodium chloride

干预措施: gatifloxacin ophthalmic solution 0.3% (Drug)

结局指标

主要结局

Percentage of Subjects With Strain Resistance of the Conjunctiva as Determined by Minimum Inhibitory Concentration (MIC) at Day 14

时间窗: Day 14

Percentage of subjects with strain resistance as determined by Minimum Inhibitory Concentration (MIC) of the conjunctiva (clear membrane covering the white surface of the eye) at day 14. MIC is the lowest concentration of an antimicrobial that inhibits the visible growth of a microorganism after incubation. The MIC cut-off values include: Intermediate is 1 to less than 2; Resistant is greater than or equal to 2.

次要结局

  • Mutant Prevention Concentration (MPC) of the Conjunctiva at Day 14(Day 14)
  • Minimum Inhibitory Concentration 50 (MIC50) at Day 14(Day 14)
  • Minimum Inhibitory Concentration 90 (MIC90) at Day 14(Day 14)
  • Minimum Inhibitory Concentration (MIC) Range at Day 14(Day 14)

研究者

发起方
Allergan
申办方类型
Industry
责任方
Sponsor

相似试验